Australis Capital Inc
CNSX:AUSA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
A
|
Australis Capital Inc
CNSX:AUSA
|
7.5m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
280B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.1B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.5B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
97B EUR |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Australis Capital Inc
Glance View
Australis Capital, Inc. operates as a multi-state operator in the cannabis industry in the U.S. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2018-09-18. The firm through its subsidiary 2750176 Ontario Inc. provides in facility design, construction management and (post) commissioning services to the horticultural sector across a range of commercial crops. The company operates horticulture projects across the globe, including the United States, Canada, Denmark Finland, Iceland, Germany, Netherlands, Bahrein, United Arab Emirates, Southeast Asia and Australia. Its subsidiaries include Australis Capital (Nevada) Inc., Australis Holdings LLP, Rthm Technologies Inc., Audacious WR LLC, Australis Perennial LLC, Australis Prosper LLC, Australis Terrain LLC, Coccon Technology LLC, and Australis CA LLC.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 2 years, Australis Capital Inc’s Net Margin has increased from -3 199.6% to -220.7%. During this period, it reached a low of -12 789.2% on Dec 31, 2020 and a high of -220.7% on Jan 31, 2022.
